Home » Covid, the circular: yes to the Pfizer vaccine against Omicron 4 and 5 for children between 5 and 11 years

Covid, the circular: yes to the Pfizer vaccine against Omicron 4 and 5 for children between 5 and 11 years

by admin
Covid, the circular: yes to the Pfizer vaccine against Omicron 4 and 5 for children between 5 and 11 years

Yes to Pfizer vaccine against Omicron Ba.4 and Ba.5 for children between 5 and 11 years. IS The circular of the Ministry of Health has been published, incorporating the opinion of the technical-scientific commission of the Medicines Agency, with the green light for Pfizer’s Cominarty vaccine against the Omicron Ba.4 and Ba.5 variants as a booster for children in the 5-11 age group. The serum is recommended for the most fragile children but, at the request of the parents, it can be administered to all those in the age group. In its session of last December 5, AIFA, accepting the opinion expressed by the European Medicines Agency (EMA), had already authorized the Original/Omicron BA.4-5 formulation (5/5 micrograms).

Covid, Kraken variant, ECDC: “Dominant in Europe in 1-2 months, but does not give more serious disease”. WHO: “Use masks indoors”

by Elena Dusi


“The recommendation of the booster dose is extended to children in the 5-11 year age group (included), who present conditions of fragility such as to expose them to the development of more severe forms of SARS-CoV-2 infection” reads the circular .
“Moreover – specifies the ministry – taking into account the indication of use authorized by Ema and Aifa, this formulation may also be made available for the recall of children, in the 5-11 age group (included), who do not present these conditions , at the request of the parent or whoever has parental authority”.

See also  Escape from Beccaria, the head of juvenile prisons: "Me, worried about the discomfort of these kids on the run"

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy